Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
4CPg3u1a6pKsQxg5
Listen
